{
    "organizations": [],
    "uuid": "8b7a3962e945771c34e290e0bb42dfc933b6e8b4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vbi-vaccines-announces-completion/brief-vbi-vaccines-announces-completion-of-enrollment-in-protect-phase-3-clinical-study-for-sci-b-vac-hepatitis-b-vaccine-idUSFWN1RW0J4",
    "ord_in_thread": 0,
    "title": "BRIEF-VBI Vaccines Announces Completion Of Enrollment In Protect Phase 3 Clinical Study For Sci-B-Vac Hepatitis B Vaccine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - VBI Vaccines Inc:\n* VBI VACCINES ANNOUNCES COMPLETION OF ENROLLMENT IN PROTECT PHASE 3 CLINICAL STUDY FOR SCI-B-VACÂ® HEPATITIS B VACCINE\n* VBI VACCINES INC - TOPLINE DATA FROM PROTECT STUDY ARE EXPECTED MID-YEAR 2019 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-19T20:02:00.000+03:00",
    "crawled": "2018-04-20T12:03:13.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "vbi",
        "vaccine",
        "inc",
        "vbi",
        "vaccine",
        "announces",
        "completion",
        "enrollment",
        "protect",
        "phase",
        "clinical",
        "study",
        "hepatitis",
        "b",
        "vaccine",
        "vbi",
        "vaccine",
        "inc",
        "topline",
        "data",
        "protect",
        "study",
        "expected",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}